858 Therapeutics
San Diego, United States · Founded 2019
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- 8five8tx.com
- Last Round
- Series BSep 2024
- Rounds
- 2
About
858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule therapeutics directed against novel oncology and immunology targets. Its lead programs focus on important nodes in cancer biology, including DNA damage repair, innate immunity, and RNA epigenetics, and expands on decades of drug discovery experience by the founders. 858 is headquartered in the biotech hub of San Diego, CA. For more information, please visit www.8five8tx.com.
Summary
858 Therapeutics is a Life Sciences company based in San Diego, United States, founded in 2019. Its most recent funding was a Series B round in Sep 2024. Investors include Avidity Partners, Jerel Davis and Insight Partners.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...